An update on prostate cancer
- 1 May 2001
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 13 (3) , 204-211
- https://doi.org/10.1097/00001622-200105000-00013
Abstract
Consideration of the number of prostate biopsy samples found to be positive for cancer may add clinically useful information to T stage, Gleason score, and prostate-specific antigen level in predicting outcome after radical prostatectomy. Higher radiation doses and neoadjuvant hormone therapy has been applied successfully to patients with higher risk disease. Brachytherapy has emerged as a modality for localized prostate cancer with outcomes and toxicity being further defined. Efforts to measure and improve quality of life are an important part of prostate cancer research. Standard management of metastatic disease remains androgen ablation, with long-term side effects being recognized. Newer hormonal and chemotherapeutic agents are being explored for patients with metastatic disease.Keywords
This publication has 44 references indexed in Scilit:
- Biochemical Outcome Following External Beam Radiation Therapy With or Without Androgen Suppression Therapy for Clinically Localized Prostate CancerJAMA, 2000
- Clinical Utility of the Percentage of Positive Prostate Biopsies in Defining Biochemical Outcome After Radical Prostatectomy for Patients With Clinically Localized Prostate CancerJournal of Clinical Oncology, 2000
- Examining the Role of Neoadjuvant Androgen Deprivation in Patients Undergoing Prostate BrachytherapyJournal of Clinical Oncology, 2000
- Higher than standard radiation doses (≥72 Gy) with or without androgen deprivation in the treatment of localized prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Importance of high radiation doses (72 Gy or greater) in the treatment of Stage T1-T3 adenocarcinoma of the prostateUrology, 2000
- THE PERCENT OF CORES POSITIVE FOR CANCER IN PROSTATE NEEDLE BIOPSY SPECIMENS IS STRONGLY PREDICTIVE OF TUMOR STAGE AND VOLUME AT RADICAL PROSTATECTOMYJournal of Urology, 2000
- Prostate cancer risk and consumption of fish oils: A dietary biomarker-based case–control studyBritish Journal of Cancer, 1999
- ?-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinomaCancer, 1999
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997